Related Experiment Video
Updated: Jul 29, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma
Nikolina Piteša1, Matea Kurtović1, Nenad Bartoniček2,3
1Ruđer Bošković Institute, Division of Molecular Medicine, 10 000 Zagreb, Croatia.
Background:
Melanoma represents the deadliest skin cancer due to its cell plasticity which results in high metastatic potential and chemoresistance. Melanomas frequently develop resistance to targeted therapy; therefore, new combination therapy strategies are required. Non-canonical signaling interactions between HH-GLI and RAS/RAF/ERK signaling were identified as one of the drivers of melanoma pathogenesis. Therefore, we decided to investigate the importance of these non-canonical interactions in chemoresistance, and examine the potential for HH-GLI and RAS/RAF/ERK combined therapy.
Methods:
We established two melanoma cell lines resistant to the GLI inhibitor, GANT-61, and characterized their response to other HH-GLI and RAS/RAF/ERK inhibitors.
Results:
We successfully established two melanoma cell lines resistant to GANT-61. Both cell lines showed HH-GLI signaling downregulation and increased invasive cell properties like migration potential, colony forming capacity, and EMT. However, they differed in MAPK signaling activity, cell cycle regulation, and primary cilia formation, suggesting different potential mechanisms responsible for resistance occurrence.
Conclusions:
Our study provides the first ever insights into cell lines resistant to GANT-61 and shows potential mechanisms connected to HH-GLI and MAPK signaling which may represent new hot spots for noncanonical signaling interactions.
Insights
New melanoma cell lines resistant to GANT-61 show altered HH-GLI and MAPK signaling, suggesting new therapeutic targets for combination therapy against this deadly skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma is a deadly skin cancer characterized by cell plasticity, leading to metastasis and chemoresistance.
- Targeted therapies for melanoma often face resistance, necessitating novel combination strategies.
- Non-canonical interactions between HH-GLI and RAS/RAF/ERK signaling pathways are implicated in melanoma development.
Purpose of the Study:
- To investigate the role of non-canonical HH-GLI and RAS/RAF/ERK signaling in melanoma chemoresistance.
- To explore the potential of combined HH-GLI and RAS/RAF/ERK pathway inhibition as a therapeutic strategy.
Main Methods:
- Establishment of two melanoma cell lines resistant to the GLI inhibitor GANT-61.
- Characterization of these resistant cell lines' response to HH-GLI and RAS/RAF/ERK pathway inhibitors.
Main Results:
- Successfully generated GANT-61 resistant melanoma cell lines.
- Observed HH-GLI signaling downregulation and increased invasive properties (migration, colony formation, EMT) in resistant cells.
- Identified differential MAPK signaling activity, cell cycle regulation, and primary cilia formation, indicating diverse resistance mechanisms.
Conclusions:
- This study presents the first characterization of GANT-61 resistant melanoma cell lines.
- Potential mechanisms involving HH-GLI and MAPK signaling in chemoresistance were identified.
- These findings highlight novel non-canonical signaling interactions as potential therapeutic targets in melanoma.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
MAPK Signaling Cascades
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Amplifying Signals via Enzymatic Cascade
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

